Cubist Systematic Strategies, LLC Vincerx Pharma, Inc. Transaction History

Cubist Systematic Strategies, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.0 - $1.72 $0 - $6,419	-3,732 Reduced 35.04%	6,920 $10,000
Q2 2022 Aug 15, 2022	SELL	$0.0 - $0.0 $0 - $0	-6,616 Reduced 38.31%	10,652 $14,000
Q1 2022 May 16, 2022	BUY	$0.0 - $0.0 $0 - $0	13,029 Added 307.36%	17,268 $69,000
Q4 2021 Feb 14, 2022	BUY	$0.0 - $0.0 $0 - $0	2,704 Added 176.16%	4,239 $43,000
Q3 2021 Nov 15, 2021	BUY	$0.0 - $0.0 $0 - $0	1,535 New	1,535 $25,000

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.